Typhoid conjugate vaccines: Advancing the research and public health agendas
The disease burden of typhoid fever remains high in endemic areas in Asia and Africa, especially in children. Recent clinical trials conducted by the Typhoid Vaccine Acceleration Consortium show typhoid conjugate vaccine (TCV) to be safe, immunogenic, and efficacious at preventing blood culture-conf...
Principais autores: | Birkhold, M, Mwisongo, A, Pollard, AJ, Neuzil, KM |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Oxford University Press
2021
|
Registros relacionados
-
Accelerating typhoid conjugate vaccine introduction: what can be learned from prior new vaccine introduction initiatives?
por: Jamka, LP, et al.
Publicado em: (2019) -
Introduction of typhoid conjugate vaccines in Africa and Asia
por: Neuzil, K, et al.
Publicado em: (2019) -
Early insights from clinical trials of typhoid conjugate vaccine
por: Neuzil, KM, et al.
Publicado em: (2020) -
Prospects of future typhoid and paratyphoid vaccines in endemic countries
por: Shakya, M, et al.
Publicado em: (2021) -
Typhoid conjugate vaccines: a step towards typhoid control
por: Shakya, M, et al.
Publicado em: (2024)